211 related articles for article (PubMed ID: 23091812)
1. Type and cause of liver disease in Korea: single-center experience, 2005-2010.
Lee SS; Byoun YS; Jeong SH; Kim YM; Gil H; Min BY; Seong MH; Jang ES; Kim JW
Clin Mol Hepatol; 2012 Sep; 18(3):309-15. PubMed ID: 23091812
[TBL] [Abstract][Full Text] [Related]
2. [Alcoholic liver diseases in Japan and modification by hepatitis virus].
Horie Y; Yamagishi Y; Ishii H
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2003 Oct; 38(5):403-14. PubMed ID: 14639919
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease, and chronic liver disease of unknown etiology: report of the nationwide survey.
Tokushige K; Hashimoto E; Horie Y; Taniai M; Higuchi S
J Gastroenterol; 2011 Oct; 46(10):1230-7. PubMed ID: 21748549
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.
Tateishi R; Okanoue T; Fujiwara N; Okita K; Kiyosawa K; Omata M; Kumada H; Hayashi N; Koike K
J Gastroenterol; 2015 Mar; 50(3):350-60. PubMed ID: 24929638
[TBL] [Abstract][Full Text] [Related]
5. [Is the prevalence of cryptogenic hepatocellular carcinoma increasing in Korea?].
Oh KC; Park SH; Park JC; Jin DK; Park CS; Kim KO; Jang HJ; Lee JY; Park CH; Han TH; Yoo KS; Kim JH; Kim DJ; Lee MS; Park CK
Korean J Gastroenterol; 2005 Jan; 45(1):45-51. PubMed ID: 15665567
[TBL] [Abstract][Full Text] [Related]
6. Global burden of liver disease: 2023 update.
Devarbhavi H; Asrani SK; Arab JP; Nartey YA; Pose E; Kamath PS
J Hepatol; 2023 Aug; 79(2):516-537. PubMed ID: 36990226
[TBL] [Abstract][Full Text] [Related]
7. Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates.
Younossi Z; Stepanova M; Ong JP; Jacobson IM; Bugianesi E; Duseja A; Eguchi Y; Wong VW; Negro F; Yilmaz Y; Romero-Gomez M; George J; Ahmed A; Wong R; Younossi I; Ziayee M; Afendy A;
Clin Gastroenterol Hepatol; 2019 Mar; 17(4):748-755.e3. PubMed ID: 29908364
[TBL] [Abstract][Full Text] [Related]
8. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013.
Beste LA; Leipertz SL; Green PK; Dominitz JA; Ross D; Ioannou GN
Gastroenterology; 2015 Nov; 149(6):1471-1482.e5; quiz e17-8. PubMed ID: 26255044
[TBL] [Abstract][Full Text] [Related]
9. Risk Factors for Cirrhosis in Contemporary Hepatology Practices-Findings From the Texas Hepatocellular Carcinoma Consortium Cohort.
El-Serag HB; Kanwal F; Feng Z; Marrero JA; Khaderi S; Singal AG;
Gastroenterology; 2020 Jul; 159(1):376-377. PubMed ID: 32234536
[No Abstract] [Full Text] [Related]
10. Risk factors for hepatocellular carcinoma by age, sex, and liver disorder status: A prospective cohort study in Korea.
Yi SW; Choi JS; Yi JJ; Lee YH; Han KJ
Cancer; 2018 Jul; 124(13):2748-2757. PubMed ID: 29669170
[TBL] [Abstract][Full Text] [Related]
11. Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea.
Jang WY; Chung WJ; Jang BK; Hwang JS; Lee HJ; Hwang MJ; Kweon YO; Tak WY; Park SY; Lee SH; Lee CH; Kim BS; Kim SH; Suh JI; Park JG
J Korean Med Sci; 2020 Jul; 35(29):e233. PubMed ID: 32715667
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: The multiethnic cohort.
Setiawan VW; Stram DO; Porcel J; Lu SC; Le Marchand L; Noureddin M
Hepatology; 2016 Dec; 64(6):1969-1977. PubMed ID: 27301913
[TBL] [Abstract][Full Text] [Related]
13. Clinical, Epidemiological and Histopathological Aspects in Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation.
Tunissiolli NM; Castanhole-Nunes MMU; Pavarino ÉC; da Silva RF; da Silva RCMA; Maria Goloni-Bertollo E
Asian Pac J Cancer Prev; 2018 Oct; 19(10):2795-2802. PubMed ID: 30360608
[TBL] [Abstract][Full Text] [Related]
14. Current status of liver diseases in Korea: toxic and alcoholic liver diseases.
Kim KA
Korean J Hepatol; 2009 Dec; 15 Suppl 6():S29-33. PubMed ID: 20037277
[TBL] [Abstract][Full Text] [Related]
15. Liver diseases: Perspective from the Philippines.
Ornos ED; Murillo KJ; Ong JP
Ann Hepatol; 2023; 28(3):101085. PubMed ID: 36889673
[TBL] [Abstract][Full Text] [Related]
16. Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.
Chan TT; Chan WK; Wong GL; Chan AW; Nik Mustapha NR; Chan SL; Chong CC; Mahadeva S; Shu SS; Lai PB; Chan HL; Wong VW
Am J Gastroenterol; 2020 Jun; 115(6):867-875. PubMed ID: 32149781
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics analysis of 1180 patients with hepatocellular carcinoma secondary to hepatitis B, hepatitis C and alcoholic liver disease.
Zhao H; Zhu P; Han T; Ye Q; Xu C; Wu L; Liu F; Yin W; Li Z; Guo Y
J Clin Lab Anal; 2020 Feb; 34(2):e23075. PubMed ID: 31659795
[TBL] [Abstract][Full Text] [Related]
18. The Changing Global Epidemiology of Hepatocellular Carcinoma.
Caines A; Selim R; Salgia R
Clin Liver Dis; 2020 Nov; 24(4):535-547. PubMed ID: 33012444
[TBL] [Abstract][Full Text] [Related]
19. A study of the awareness of chronic liver diseases among Korean adults.
Jun DW; Cho YK; Sohn JH; Lee CH; Kim SH; Eun JR
Korean J Hepatol; 2011 Jun; 17(2):99-105. PubMed ID: 21757980
[TBL] [Abstract][Full Text] [Related]
20. [National survey of alcoholic liver disease in Japan].
Horie Y; Ishii H; Hibi T
Nihon Arukoru Yakubutsu Igakkai Zasshi; 2004 Dec; 39(6):505-10. PubMed ID: 15675363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
